Greenway Releases Q1 Financial Results

KINGSVILLE, ON – August 27, 2025 – Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF), a key player in Canada’s cannabis cultivation scene, specializing in high-quality greenhouse-grown product, has released its unaudited condensed interim financial statements for the first quarter ending June 30, 2025. Let’s crunch the numbers and see what’s budding for this Canadian cultivator.

The report reveals a fascinating narrative of strategic maneuvering and bottom-line bolstering.

Here’s a snapshot of the quarter’s highlights (all figures in Canadian dollars):

• Price Surge: Average net sales price per gram skyrocketed to $1.71, a 54% leap from Q1 F2025 ($1.11). Simultaneously, cash cost per gram of finished goods pruned down to $0.70 (from $0.92 in Q4 F2025). This marks the most significant gap between sales price and cash cost in Greenway’s history — a clear signal of enhanced efficiency and pricing power.
• Revenue Dip, Profit Bloom: Net cannabis revenue clocked in at $1,621,062 (compared to $2,394,159 in Q1 F2025). While revenue took a slight hit, gross profit blossomed to $841,227 (up from $342,922).
• Margin Expansion: Gross margin surged, hitting 50% (a massive jump from Q1 F2025’s 14%). Even before fair value adjustments, the gross margin climbed to 30%, doubling the previous year’s 14%.
• EBITDA Adjustment: Adjusted EBITDA stood at $78,723 (down from $316,431).
• Loss Reduction: The net loss narrowed significantly to $166,453, a $375,025 (69%) improvement year-over-year, primarily fueled by the improved gross margin.
• Inventory Stockpile: Greenway boasted a finished goods inventory of 1,274,617 grams, valued at $1,174,581, positioning them well to fulfill incoming purchase orders.
• Solid Financial Foundation: A cash balance of $2,192,005 coupled with positive working capital (excluding related party amounts) of $4,203,627 paints a picture of financial stability.

Global Ambitions Take Root

The company isn’t just focused on the Canadian market. On July 31, 2025, Greenway inked a supply agreement with 4C LABS, a U.K.-based medical cannabis leader. This partnership will see Greenway supplying high-quality dried flower to one of the U.K.’s prominent importers and distributors of cannabis-based pharmaceuticals. This strategic move to increase finished goods inventory indicates a proactive approach to meet the demands of these international partnerships.

“This quarter highlights the resilience of our business model and the dedication of our team,” noted Jamie D’Alimonte, CEO of Greenway. “Even with lower volumes, we achieved substantial price increases, boosted gross margins, and significantly reduced net losses. Our strategic focus is to align production with the most lucrative channels – wholesale, branded products, and international sales.”

Carl Mastronardi, President of Greenway, added, “We’ve fortified our balance sheet while lowering cash costs per gram. With over 1.2 million grams in finished goods inventory, Greenway is primed to capitalize on both domestic and worldwide opportunities, especially through sales agreements like the 4C LABS deal in the U.K. This should help us sustain our current sales price while boosting quarterly volume as we move forward.”

For those keen to delve deeper, the unaudited condensed interim financial statements for the quarter ending June 30, 2025, are available at www.sedarplus.ca.

Non-IFRS Measures

To better understand Greenway’s performance, management utilizes a non-IFRS measure. Adjusted EBITDA, while valuable for assessing operational efficiency, should be viewed alongside IFRS measures for a comprehensive financial picture. Refer to the Company’s Management’s Discussion and Analysis for a breakdown of Adjusted EBITDA and its reconciliation to IFRS standards.

About Greenway

Greenway Greenhouse Cannabis Corporation is a federally licensed cultivator operating in Kingsville, Ontario. They are focused on becoming a leading cannabis cultivator in Canada. More information can be found on Greenway.ca.

A Word of Caution

This news release contains forward-looking statements subject to risks and uncertainties, as detailed in the Company’s prospectus. Actual results may differ materially from those projected.